FB2026_01 , released March 12, 2026
FB2026_01 , released March 12, 2026
Human Disease Model Report: gastric cancer, hereditary diffuse, CDH1-related
Open Close
General Information
Name
gastric cancer, hereditary diffuse, CDH1-related
FlyBase ID
FBhh0000608
Disease Ontology Term
Parent Disease
Overview

This report describes the form of hereditary diffuse gastric cancer (HDGC) caused by mutational variants in the human CDH1 gene. HDGC is a predisposition to development of certain cancers; it exhibits autosomal dominant inheritance. The CDH1 gene encodes epithelial cadherin, which is involved in mechanisms regulating cell-cell adhesions, and mobility and proliferation of epithelial cells; it has been identified as a tumor suppressor protein. The syndrome implicating CDH1 in gastric cancer is also associated with an oral facial cleft phenotype. There are multiple cadherin genes in both human and fly (see FBgg0000105). CDH1 has been implicated in susceptibility to multiple types of cancer; this Drosophila model makes use of variants specifically associated with hereditary diffuse gastric cancer.

Multiple UAS constructs of the human Hsap\CDH1 gene have been introduced into flies, including wild-type and variants associated with HDGC. See the 'Disease-Implicated Variants' table below.

[updated Mar. 2024 by FlyBase; FBrf0222196]

Disease Summary Information
Disease Summary: gastric cancer, hereditary diffuse, CDH1-related
OMIM report

[DIFFUSE GASTRIC AND LOBULAR BREAST CANCER SYNDROME; DGLBC](https://omim.org/entry/137215)

Human gene(s) implicated

[CADHERIN 1; CDH1](https://omim.org/entry/192090)

Symptoms and phenotype

Heterozygous CDH1 mutation carriers have a 70 to 80% lifetime risk of developing diffuse gastric cancer. In addition to gastric cancer, up to 60% of female mutation carriers develop lobular carcinoma of the breast, and some carriers may develop colorectal cancer. [from MIM:137215; 2017.09.11]

Genetics

Hereditary diffuse gastric cancer is an autosomal dominant cancer predisposition syndrome caused by heterozygous germline mutation in the E-cadherin gene (CDH1). Heterozygous CDH1 mutation carriers have a 70 to 80% lifetime risk of developing diffuse gastric cancer. [from MIM:137215; 2017.09.11]

Cellular phenotype and pathology
Molecular information

CDH1 is involved in mechanisms regulating cell-cell adhesions, mobility and proliferation of epithelial cells; it has been identified as a tumor suppressor protein. [Gene Cards, CDH1; 2017.09.11]

The CDH1 gene encodes epithelial cadherin (E-cadherin). The cadherin superfamily represents a diverse group of transmembrane receptors which mediate calcium-dependent cell-cell adhesion.

External links
Disease synonyms
diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate
familial gastric cancer
gastric cancer, familial diffuse
HDGC
hereditary diffuse gastric cancer
Ortholog Information
Human gene(s) in FlyBase
Human gene (HGNC)
Symbol / Name
D. melanogaster ortholog (based on DIOPT)
Comments on ortholog(s)

There are multiple cadherin genes in both species; see FBgg0000105.

Other mammalian ortholog(s) used
    D. melanogaster Gene Information (0)
    Other Genes Used: Viral, Bacterial, Synthetic (0)
      Summary of Physical Interactions (0 groups)
      Alleles Reported to Model Human Disease (Disease Ontology) (8 alleles)
      Alleles Representing Disease-Implicated Variants
      Genetic Tools, Stocks and Reagents
      Sources of Stocks
      Contact lab of origin for a reagent not available from a public stock center.
      Bloomington Stock Center Disease Page
      Related mammalian, viral, bacterial, or synthetic transgenes
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila transgenes
      Allele
      Transgene
      Publicly Available Stocks
      RNAi constructs available
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila classical alleles
      Allele
      Allele class
      Mutagen
      Publicly Available Stocks
      References (10)